First Affiliated Hospital of Guangzhou Medical University · 1×
×1.419k/14kID
×1.026k/25kPRM
×0.911k/12kCR
×1.413k/9kIMMUN
×1.73k/2kIA
Citations per year
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
'26
Countries citing scholars working at State Key Laboratory of Respiratory Disease
Since Specialization
Citations
This map shows the geographic impact of research produced by authors working at State Key Laboratory of Respiratory Disease. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by papers produced at State Key Laboratory of Respiratory Disease with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites State Key Laboratory of Respiratory Disease more than expected).
Fields of papers published by authors at State Key Laboratory of Respiratory Disease
This network shows the impact of papers affiliated with State Key Laboratory of Respiratory Disease at the time of their publication. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers affiliated with State Key Laboratory of Respiratory Disease at the time of their publication.
About State Key Laboratory of Respiratory Disease
In recent decades, authors affiliated with State Key Laboratory of Respiratory Disease have published 6.3k papers, which have received a total of 145.3k indexed citations . Scholars at this organization have produced 1.4k papers in Pulmonary and Respiratory Medicine, 587 papers in Infectious Diseases, 180 papers in Immunology and Allergy, 586 papers in Immunology and 384 papers in Cancer Research on the topics of Chronic Obstructive Pulmonary Disease (COPD) Research (323 papers), Asthma and respiratory diseases (316 papers), SARS-CoV-2 and COVID-19 Research (236 papers), Nanoplatforms for cancer theranostics (184 papers), Catalytic C–H Functionalization Methods (183 papers), RNA modifications and cancer (168 papers), Lung Cancer Treatments and Mutations (162 papers) and Lung Cancer Diagnosis and Treatment (149 papers). Their work is cited by papers focused on Infectious Diseases (19.1k citations), Pulmonary and Respiratory Medicine (25.8k citations), Cancer Research (10.9k citations), Immunology (12.6k citations) and Immunology and Allergy (3.1k citations). Authors at State Key Laboratory of Respiratory Disease collaborate with scholars in China, United States and Hong Kong and have published in prestigious journals including Frontiers in Immunology, PLoS ONE, Scientific Reports, International Journal of COPD and Respiratory Research. Some of State Key Laboratory of Respiratory Disease's most productive authors include Nanshan Zhong, Jianxing He, Qiang Zhu, Wei‐jie Guan, Wenhua Liang, Yimin Li, Pixin Ran, Haibo Zhang, Shiyue Li and Ruchong Chen.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive
bibliographic database. While OpenAlex provides broad and valuable coverage of the global
research landscape, it—like all bibliographic datasets—has inherent limitations. These include
incomplete records, variations in author disambiguation, differences in journal indexing, and
delays in data updates. As a result, some metrics and network relationships displayed in
Rankless may not fully capture the entirety of a scholar's output or impact.
Explore institutions with similar magnitude of impact